Email Medtest Medtest Headquarters Medtest Facebook Medtest Linkedin

MedTest announces an Automated On-Board Lyse Application for Hemoglobin A1c (HbA1c) on the Mindray™ BS-200 Chemistry Analyzer

Feb 25, 2015 - press releases

For Immediate Release: (Canton, Michigan)  MedTest announces the availability of an application that enables whole blood samples to automatically be lysed on-board the Mindray™ BS-200 Chemistry Analyzer prior to analysis for Hemoglobin A1c (HbA1c).   The Mindray™ BS-200 Chemistry Analyzer, whose menu includes general chemistry and urine drugs of abuse screening tests, meets the testing needs of small-volume laboratories while offering state-of-the-art features commonly found on large volume analyzers.

MedTest is the exclusive US distributor of the Mindray™ BS-200 Chemistry Analyzer, including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets.  Automating the whole blood sample lyse procedure on-board the Mindray™ BS-200 Analyzer eliminates manual, off-line sample preparations resulting in significant timesaving and improving overall laboratory workflow.  The HbA1c assay on the Mindray™ BS-200 is CLIA classified as “moderately” complex.

Hanjoon Ryu, CEO of MedTest, stated: “We are pleased to be able to offer this solution for processing Hemoglobin A1c whole blood samples on the Mindray™ BS-200 analyzer.   Helping our customers meet their workflow efficiency goals is paramount to MedTest’s focus on delivering the “right” products and services to our laboratory customers.”

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a US-based company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.  In October 2014, MedTest acquired Clinitox Diagnostics, a Canadian company that offers drug confirmatory testing solutions via LC/MS.

For additional information, please contact:

MedTest
Debbie Whitehair, MT(ASCP)SC
Vice President, Marketing
484-748-1603
dwhitehair@medtest.com
www.medtest.com

                                                              

PR-M1111-01   02/15

Mindray Announces Registration of the BS-200 and BS-480 Chemistry Analyzers with Health Canada

Jan 22, 2015 - press releases

For Immediate Release: (Mahwah, New Jersey)  Mindray announced today that it has received a Medical Device License (#94555) from Health Canada to market and sell the Mindray BS-200 Chemistry Analyzer and the Mindray BS-480 Chemistry Analyzer into the Canadian laboratory market. 

The Mindray BS-200 Chemistry Analyzer is a bench top system offering state-of-the art features commonly found on large volume analyzers. It produces 200 photometric test results per hour and 330 tests per hour with electrolytes.  A comprehensive chemistry and urine drugs of abuse screening menu is a perfect low cost solution for low to mid volume laboratories.

The Mindray BS-480 Chemistry Analyzer meets the testing needs of mid-volume laboratories producing 400 photometric test results per hour, 240 electrolyte tests per hour with an overall throughput of 560 tests per hour.  Advanced features of the BS-480 analyzer include numerous automatic processes such as Auto-Start-Up, -QC, -Rerun, -Pre-dilution, -Post-dilution, -ISE Calibration, -Probe Cleaning, -Reagent Blank Checks and -Probe Collision Recovery which provides the laboratory with smooth operational and enhanced workflow efficiencies.  The BS-480 analyzer will feature a broad chemistry and urine drugs of abuse test menu including Vitamin D, currently in development.

Finn Li, Ph.D., General Manager of Mindray IVD North America, stated:  “We are excited to launch the BS-200 and the BS-480 analyzers into the Canadian laboratory market.  Mindray enjoys satisfied customer experiences with these analyzers and looks forward to adding Canadian customers to our installed base. 

MedTest is the exclusive US distributor of the BS-200 and the BS-480 Chemistry Analyzers including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets.  The BS-200 and BS-480 Chemistry Analyzers and reagents will be exclusively sold in Canada by Clinitox Diagnostix, a MedTest Company.  Hanjoon Ryu, CEO of MedTest, stated: “Canadian laboratories deserve an integrated service provider who offers innovative instruments with proven quality reagents, superior customer support and recognized economic advantages.  Clinitox Diagnostix, a MedTest Company, is delighted to share this announcement with our strategic partner, Mindray.”

About Mindray:  Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains the global headquarters in Shenzhen, China, the U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From the main manufacturing and engineering base in China, Mindray supplies through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems.

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.  In October, MedTest acquired Clinitox Diagnostix based in Toronto. 

For additional information, please contact:                                                                                              

Mindray™  MedTest
Finn Li, Ph.D. Debbie Whitehair, MT(ASCP)SC
General Manager, Mindray™ IVD North America    Vice President, Marketing
905-886-0589 Ext. 2158      484-748-1603
Finn.Li@mindray.com     dwhitehair@medtest.com
www.mindraynorthamerica.com       www.medtest.com

                                                                                             

PR-M1112-03   01/15

MedTest announces Commercial Launch of the Mindray™ BS-480 Chemistry Analyzer

Nov 11, 2014 - press releases

(Canton, Michigan)  MedTest announces the commercial launch of the Mindray™ BS-480 Chemistry Analyzer for use in clinical laboratories in the United States.  The Mindray BS-480 Analyzer meets the testing needs of mid-volume laboratories while offering state-of-the-art features commonly found on large volume analyzers.

The Mindray™ BS-480 Analyzer produces 400 photometric test results per hour, 240 ISE tests per hour with an overall throughput of 560 tests per hour.  Advanced features of the Mindray™ BS-480 analyzer include numerous automatic processes such as Auto-Start-Up, QC, Rerun, Pre-dilution, Post-dilution, ISE Calibration, Probe Cleaning, Reagent Blank Checks and Probe Collision Recovery which provides the laboratory with smooth operational and enhanced workflow efficiencies. 

MedTest is the exclusive US distributor of the Mindray™ BS-480 Chemistry Analyzer including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets.  The initial menu includes drugs of abuse reagents for urine drug screening.  A full menu of chemistry tests including specialty tests like HbA1c and Vitamin D are currently in development.  

Hanjoon Ryu, CEO of MedTest, stated: “MedTest is privileged to provide this analyzer to the mid-volume laboratory.  Our customers deserve an integrated service provider who offers innovative instruments with proven quality reagents, superior customer support and recognized economic advantages.  Partnered with the bench-top Mindray™ BS-200 Chemistry Analyzer, the Mindray™ BS-480 Analyzer enables MedTest to offer a unique testing solution for the Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) in the United States.  Our solution will provide commutable testing results between the core laboratory and satellite laboratory.”

About Mindray:  Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains global headquarters in Shenzhen, China, and Mahwah, New Jersey with multiple sales offices worldwide. From the main manufacturing and engineering base in China, Mindray supplies through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems.

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.

 

For additional information, please contact:

 

Debbie Whitehair, MT(ASCP)SC

Vice President, Marketing

484-748-1603

dwhitehair@medtest.com

www.medtest.com

 

PR-M1112-02   11/14

MedTest Announces Acquisition of Clinitox Diagnostix

Oct 28, 2014 - press releases

(Canton, Michigan)  MedTest Holdings (“MedTest”), the parent company of MedTest DX and Pointe Scientific, has signed a definitive agreement to acquire Clinitox Diagnostix located in Mississauga, Ontario, Canada.  MedTest is an in-vitro diagnostics company providing automated, fast and cost-effective blood and urine testing solutions for diabetes, cardiovascular disease, urine drugs of abuse screening and wellness testing.

Clinitox Diagnostix was founded in 2010 by Howard Lee.  Clinitox Diagnostix provides drugs of abuse confirmatory testing capabilities via liquid chromatography/mass spectrophotometry (LC/MS) instrumentation and associated reagents and consumables as pre-packaged kits.  Implementation consulting provides the customer with on-site assistance in setting up their LC/MS testing and developing the standard operating procedures enabling the laboratory to initiate testing sooner and reduce costly start-up costs.

Hanjoon Ryu, CEO of MedTest, stated:  “The addition of Clinitox Diagnostix to our portfolio enables us to become a highly differentiated provider of extensive solutions in the drugs of abuse testing market.  Now we can provide the laboratory with confirmatory drugs of abuse testing capability in addition to the urine drugs of abuse screening testing that can be performed on the Mindray™ BS-200 and BS-480 Chemistry Analyzers.  Our clinical expertise in the drugs of abuse testing market meets both individual laboratory testing needs as well as the needs of the growing hub-and-spoke regional toxicology networks.”

In addition to manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets, MedTest is the exclusive US distributor of the Mindray™ floor model BS-480 Chemistry Analyzer and the bench-top BS-200 Chemistry Analyzer.  The acquisition of Clinitox enables MedTest to provide a more integrated service offering of innovative instruments with proven quality reagents, superior customer support and recognized economic advantages. 

For additional information, please contact:

Debbie Whitehair, MT(ASCP)SC

Vice President, Marketing

484-748-1603

dwhitehair@medtest.com

PR-M3111-01   10/14

Mindray and MedTest announce FDA 510(k) Clearance for the BS-480 Chemistry Analyzer

Sep 4, 2014 - press releases

For Immediate Release:

(Mahwah, New Jersey & Canton, Michigan)  Mindray™ and MedTest jointly announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market and sell the new Mindray™ BS-480 Chemistry Analyzer.  The Mindray™ BS-480 Analyzer meets the testing needs of mid-volume laboratories while offering state-of-the-art features commonly found on large volume analyzers.

The BS-480 Analyzer produces 400 photometric test results per hour, 240 ISE tests per hour with an overall throughput of 560 tests per hour.  Advanced features of the BS-480 analyzer include numerous automatic processes such as Auto-Start-Up, QC, Rerun, Pre-dilution, Post-dilution, ISE Calibration, Probe Cleaning, Reagent Blank Checks and Probe Collision Recovery which provides the laboratory with smooth operational and enhanced workflow efficiencies. 

Finn Li, Ph.D., General Manager, Mindray™ IVD North America, stated:  “We are excited to launch the BS-480 analyzer into the United States laboratory market.  Mindray™ enjoys satisfied customer experiences with this analyzer outside of the US and looks forward to adding US customers to our installed base.  As Mindray™ has grown rapidly in global markets; the commercialization of the BS-480 further enhances our presence in the US in-vitro diagnostic market, enabling us to continue to introduce new and innovative products for the clinical laboratory in the future.”

MedTest is the exclusive US distributor of the BS-480 Chemistry Analyzer including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets.  Hanjoon Ryu, MedTest’s CEO, stated: “Mid- and mid-high volume laboratories deserve a more integrated service provider who offers innovative instruments with proven quality reagents, superior customer support and recognized economic advantages.  Partnered with the bench-top BS-200 Chemistry Analyzer, the BS-480 Analyzer enables MedTest to offer a unique testing solution for the Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) in the United States.  Our solution will provide commutable testing results between the core laboratory and satellite laboratory.  We are delighted to share this announcement with our strategic partner, Mindray™.”

About Mindray™:  Mindray™ is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray™ maintains the global headquarters in Shenzhen, China, the U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From the main manufacturing and engineering base in China, Mindray™ supplies through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems.

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.

For additional information, please contact:

                                                                                              

Mindray™   MedTest
Finn Li, Ph.D. Debbie Whitehair, MT(ASCP)SC
General Manager, Mindray™ IVD North America    Vice President, Marketing
905-886-0589 Ext. 2158      484-748-1603
Finn.Li@mindray.com     dwhitehair@medtest.com
www.mindraynorthamerica.com       www.medtest.com

                                                                                             

PR-M1112-01   09/14

PREV 1 2 3 4 5 6 7 8 9 10 11 NEXT